jCyte Revenue and Competitors
Estimated Revenue & Valuation
- jCyte's estimated annual revenue is currently $2M per year.
- jCyte's estimated revenue per employee is $155,000
Employee Data
- jCyte has 13 Employees.
- jCyte grew their employee count by 8% last year.
jCyte's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder & Chief Scientific Officer | Reveal Email/Phone |
3 | President & Co-founder | Reveal Email/Phone |
4 | Chief Scientific Officer & Co-Founder | Reveal Email/Phone |
5 | Chief Technical Officer | Reveal Email/Phone |
6 | Chief Strategy Officer and General Counsel | Reveal Email/Phone |
7 | Chief Financial Officer and Treasurer | Reveal Email/Phone |
8 | Chief Development Officer | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | SVP, Manufacturing, Quality and Supply Chain | Reveal Email/Phone |
jCyte Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is jCyte?
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company's allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jCyte has completed a phase 1/2a, phase 1/2a extension and phase 2b clinical trials testing jCell in patients with Retinitis Pigmentosa.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.6M | 13 | -19% | $20M |
#2 | $1.3M | 13 | N/A | N/A |
#3 | $0.4M | 13 | -24% | $12M |
#4 | $1.2M | 14 | 17% | N/A |
#5 | $1.4M | 14 | -55% | N/A |